Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M K Barry

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Annals of Surgery|September 1, 1993
Erythromycin accelerates gastric emptying after pancreaticoduodenectomy. A prospective, randomized, placebo-controlled trialC J Yeo, M K Barry, P K Sauter, et al.
The British Journal of Surgery|March 1, 1997
Audit of colorectal cancer surgery by non-specialist surgeonsK K Singh, M K Barry, P Ralston, et al.
Surgical Oncology|February 5, 2021
Disease recurrence and oncological outcome of patients treated surgically with curative intent for estrogen receptor positive, lymph node negative breast cancerM G Davey, É J Ryan, P F McAnena, et al.
BJS Open|May 20, 2021
The impact of progesterone receptor negativity on oncological outcomes in oestrogen-receptor-positive breast cancerM G Davey, É J Ryan, P J Folan, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Annals of Surgery|September 1, 1993
Erythromycin accelerates gastric emptying after pancreaticoduodenectomy. A prospective, randomized, placebo-controlled trialC J Yeo, M K Barry, P K Sauter, et al.
The British Journal of Surgery|March 1, 1997
Audit of colorectal cancer surgery by non-specialist surgeonsK K Singh, M K Barry, P Ralston, et al.
Surgical Oncology|February 5, 2021
Disease recurrence and oncological outcome of patients treated surgically with curative intent for estrogen receptor positive, lymph node negative breast cancerM G Davey, É J Ryan, P F McAnena, et al.
BJS Open|May 20, 2021
The impact of progesterone receptor negativity on oncological outcomes in oestrogen-receptor-positive breast cancerM G Davey, É J Ryan, P J Folan, et al.
Pageof 3